The Journal of Practical Medicine >

2025 , Vol. 41 >Issue 3: 379 - 384

DOI: https://doi.org/10.3969/j.issn.1006-5725.2025.03.011

Clinical Research

The relationship between tumor necrosis factor alpha inducible protein 8 family members 2， cell proliferation nuclear antigen expression levels， and clinical pathological parameters and prognosis in endometrial cancer tissue

  • Yiyang ZHAI ,
  • Yunyi MA ,
  • Junying ZHAI ,
  • Hongli NIU ,
  • Ying. WANG
Expand
  • Department of Reproductive Gynecology，Nanyang City First People's Hospital，Nanyang 473010，He′nan，China

Received date: 2024-10-18

  Online published: 2025-02-19

Fold

Abstract

Objective To analyze the expression levels of TIPE2 and Ki67 in endometrial carcinoma （EC） and their relationship with clinicopathological parameters and prognosis. Methods Tissue samples and clinical data of 96 patients with EC who underwent surgical resection， 120 patients who underwent total hysterectomy due to uterine fibroids and 120 patients who underwent total hysterectomy or curettage admitted to our hospital from February 2020 to February 2022 were retrospectively collected as the research objects， which were divided into the EC group， the normal endometrial group and the atypical hyperplasia endometrial group， respectively. All 3 groups were followed up until March 28， 2023. Immunohistochemistry was used to detect the expression levels of TIPE2 and Ki67 in tissue samples of the three groups， and to analyze the relationship between the levels of TIPE2 and Ki67 and clinicopathological parameters and prognosis. Receiver operating characteristic curve （ROC） was used to analyze its diagnostic value for poor prognosis. Results The expression levels of TIPE2 and Ki67 in cancer tissues of the EC group were higher than those of the normal endometrial group and the atypical hyperplasia endometrial group， and those of the atypical hyperplasia endometrial group were higher than those of the normal endometrial group （P < 0.05）. The expression levels of TIPE2 and Ki67 in EC tissues were higher in patients with FIGO stage Ⅲ， lymph node metastasis， postmenopausal status， and ER and PR negative than patients with stage Ⅱ， no lymph node metastasis， premenopausal status， and ER and PR positive （P < 0.05）. Moreover， the expression level of Ki67 in EC tissues was higher in p53 positive patients than in p53 negative patients （P < 0.05）， and there was a positive correlation between the both expression levels of TIPE2 and Ki67 in EC tissues （r = 0.569， P < 0.05）. Compared with the poor prognosis group， the expression levels of TIPE2 and Ki67 in EC tissues in the good prognosis group were downregulated （P < 0.05）， and the AUC value of the combined detection of TIPE2 and Ki67 expression levels was 0.905， which was significantly higher than that of the single detection （P < 0.05）， sensitivity was 86.67% and specificity was 87.88%， and the predictive value was higher. Conclusion TIPE2 and Ki67 were highly expressed in EC tissues， and there was a positive correlation between the two， and their high expressions were related to clinicopathological features， and their combined detection had high predictive value for poor prognosis of EC.

Key words： endometrial carcinoma; tumor necrosis factor α-induced protein 8 family member 2; cell proliferating nuclear antigen; clinicopathology; prognosis; diagnosis

Cite this article

Yiyang ZHAI , Yunyi MA , Junying ZHAI , Hongli NIU , Ying. WANG . The relationship between tumor necrosis factor alpha inducible protein 8 family members 2， cell proliferation nuclear antigen expression levels， and clinical pathological parameters and prognosis in endometrial cancer tissue[J]. The Journal of Practical Medicine, 2025 , 41(3) : 379 -384 . DOI: 10.3969/j.issn.1006-5725.2025.03.011

References

1 VAN DEN HEERIK A S V M， HOREWEG N， DE BOER S M， et al. Adjuvant therapy for endometrial cancer in the era of molecular classification： Radiotherapy， chemoradiation and novel targets for therapy［J］. Int J Gynecol Cancer， 2021， 31（4）： 594-604. doi:10.1136/ijgc-2020-001822
2 OAKNIN A， BOSSE T J， CREUTZBERG C L， et al. Endometrial cancer： Esmo clinical practice guideline for diagnosis， treatment and follow-up［J］. Ann Oncol， 2022， 33（9）： 860-877. doi:10.1016/j.annonc.2022.05.009
3 CAI X， ZHANG H， WANG Y， et al. Digital pathology-based artificial intelligence models for differential diagnosis and prognosis of sporadic odontogenic keratocysts［J］. Int J Oral Sci， 2024， 16（1）： 16. doi:10.1038/s41368-024-00287-y
4 CAI Y， WANG B， XU W， et al. Endometrial cancer： Genetic， metabolic characteristics， therapeutic strategies and nanomedicine［J］. Curr Med Chem， 2021， 28（42）： 8755-8781. doi:10.2174/0929867328666210705144456
5 BAI K H， ZHANG Y Y， LI X P， et al. Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 （tipe2）： A potential novel pan-cancer immune checkpoint［J］. CSB J， 2022， 20（3）： 5226-5234. doi:10.1016/j.csbj.2022.09.021
6 HAN Z P， YANG Y， CHEN H Y， et al. Tipe2 and pcnp expression abnormalities in peripheral blood mononuclear cells associated with disease activity in rheumatoid arthritis： A meta-analysis［J］. Eur Rev Med Pharmacol Sci， 2021， 25（3）： 1242-1249.
7 曹蕾， 杨立赟， 田浩， 等. 磁共振弥散成像的ADC直方图对子宫内膜癌分级分期及Ki-67表达的评估价值 ［J］. 中国医学计算机成像杂志， 2024， 30（1）： 80-85.
8 周琦， 吴小华， 刘继红， 等.子宫内膜癌诊断与治疗指南（第四版）［J］. 中国实用妇科与产科杂志， 2018， 34（8）： 52-58.
9 张学森， 秦凯悦， 李晓菡， 等. 白藜芦醇减轻同型半胱氨酸引起的巨噬细胞免疫应答和增殖的作用［J］. 中国临床药理学杂志， 2024， 40（14）： 2038-2042.
10 吴兴旗， 党啟华， 徐晶晶， 等. 全自动免疫组化染色仪比较不同抗原修复液对p53的染色结果［J］. 临床与实验病理学杂志， 2024， 40（6）： 663-664.
11 KARPEL H C， SLOMOVITZ B， COLEMAN R L， et al. Treatment options for molecular subtypes of endometrial cancer in 2023［J］. Curr Opin Obstet Gynecol， 2023， 35（3）： 270-278. doi:10.1097/gco.0000000000000855
12 RIOS-DORIA E， MOMENI-BOROUJENI A， FRIEDMAN C F， et al. Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma［J］. Gynecol Oncol， 2023， 174（4）： 262-272. doi:10.1016/j.ygyno.2023.05.059
13 XU S， GAO X， QIU J， et al. TIPE2 acts as a tumor suppressor and correlates with tumor microenvironment immunity in epithelial ovarian cancer［J］. Aging （Albany NY）， 2023， 15（4）： 1052-1073.
14 ZHANG H， HAN W J， ZHANG Z L. The Importance of tumor necrosis factor-α-induced protein-8 like-2 in the pathogenesis of cervical cancer and preeclampsia via regulation of cell invasion［J］. Tohoku J Exp Med， 2022， 257（3）： 181-191. doi:10.1620/tjem.2022.j026
15 LASHEN A G， TOSS M S， GHANNAM S F， et al. Expression， assessment and significance of Ki67 expression in breast cancer： an update［J］. J Clin Pathol， 2023， 76（6）： 357-364. doi:10.1136/jcp-2022-208731
16 中国医师协会微无创医学专业委员会， 中国抗癌协会中西整合卵巢癌专业委员会， 张颐， 等. 卵巢肿瘤良恶性风险评估方法学中国专家共识（2024年版）［J］. 中国实用妇科与产科杂志， 2024， 40（3）： 312-320.
17 ETWEBI Z， GOLDSMITH J R， BOU-DARGHAM M， et al. Tipe2 promotes tumor initiation but inhibits tumor progression in murine colitis-associated colon cancer［J］. Inflamm Bowel Dis， 2022， 28（5）： 764-774. doi:10.1093/ibd/izab306
18 YANG X， ZHANG M， SU T， et al. Tipe2 inhibits migration and promotes apoptosis as a tumor suppressor in hypopharyngeal carcinoma［J］. Curr Protein Pept Sci， 2022， 23（6）： 424-436. doi:10.2174/1389203723666220727090317
19 REN S， FENG L， LIU H， et al. Gut microbiome affects the response to immunotherapy in non-small cell lung cancer［J］. Thorac Cancer， 2024， 15（14）： 1149-1163. doi:10.1111/1759-7714.15303
20 CHEN C， SHEN J， DU Y， et al. Characteristics of gut microbiota in patients with gastric cancer by surgery， chemotherapy and lymph node metastasis［J］. Clin Transl Oncol， 2022， 24（11）： 2181-2190. doi:10.1007/s12094-022-02875-y
21 周丽媛， 施喆， 刘悦君， 等. TIPE2 Ki67在子宫内膜癌组织中的表达及对预后的评估价值［J］. 安徽医学， 2023， 44（11）： 1334-1337.
22 WU R， YU I， TOKUMARU Y， et al. Elevated bile acid metabolism and microbiome are associated with suppressed cell proliferation and better survival in breast cancer［J］. Am J Cancer Res， 2022， 12（11）： 5271-5285.
Options
Outlines

/

〈 〉